A carregar...
Assessing the Thrombotic Risk of Patients with Essential Thrombocythemia in the Genomic Era
The molecular characterization of myeloproliferative neoplasms, including essential thrombocythemia (ET), has enabled deeper understanding of their pathogenesis. A driver lesion, namely, Janus kinase (JAK)2V617F, calreticulin (CALR) or myeloproliferative leukemia (MPL) gene mutation can be identifie...
Na minha lista:
| Publicado no: | Leukemia |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5989314/ https://ncbi.nlm.nih.gov/pubmed/28529308 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2017.150 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|